PATENT CLAIM ANALYSIS

Application Number: 16361649
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-09
Patent Classification: ["514", "331000"]

Abstract:
Disclosed herein are methods, formulations, and kits for treating or preventing a heart condition, e.g., cardiac arrhythmia, e.g., atrial arrhythmia, using selective β1 adrenergic receptor blockers. Also disclosed herein are methods, formulations, and kits for treating a heart condition via inhalation or intranasal spray administration of selective β1 adrenergic receptor blocker and class I antiarrhythmic agent.

Claim (Index 40):
The method of  claim 2 , wherein said \u03b21-selective adrenergic receptor blocker is administered concurrently with said class I antiarrhythmic agent.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 99.0
- Lexical Diversity: 1.71795
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15976516', '14632252', '15928851', '15422053', '15333953']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8209581593474159
- 35 USC 102 Novelty (BERT): 0.5618656312436444
- Combined Prediction Score: 0.7950489065370387
- Mean Citation Score: 359.47774
- Max Citation Score: 441.52908
- Similarity Product: 319.499877061615

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test